Sakai and colleagues [248] ablated AR in mesenchymal progenitors by tamoxifen-induced excision driven by platelet-derived growth factor receptor Cre-ER (PDGFR-CreER) in young, adult, and aged male mice
bremelanotide) , has been described as a promising way to treat [hypoactive sexual desire disorder],46 a condition characterized by a chronic lack of sexual desire.47 PT-141 is available as a women-only prescription under the brand name Vyleesi, clinical trials for which have shown the drug to both improve sexual desire and decrease feelings of associated distress.48 PT-141 has also been tested in men, as in a 2005 study that coadministered the peptide with sildenafil to subjects with ED who either had not responded to or could not tolerate single-therapy treatment
Weight loss effect to expect Studies across different drugs and in different populations (obese, diabetics) have shown that weight loss can be significant
Obesity is one of the biggest problems facing cat owners, and increases the risk of conditions such as heart disease, urinary issues, and cancer Obese cats are also at a significantly increased risk of developing diabetes, which requires expensive daily injections of insulin to treat